Moderna Inc (MRNA)
121.99
+10.53
(+9.45%)
USD |
NASDAQ |
May 02, 13:05
Moderna Cash from Financing (Quarterly): -109.00M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -109.00M |
September 30, 2023 | -58.00M |
June 30, 2023 | -668.00M |
March 31, 2023 | -542.00M |
December 31, 2022 | -438.00M |
September 30, 2022 | -1.041B |
June 30, 2022 | -1.327B |
March 31, 2022 | -642.00M |
December 31, 2021 | -873.00M |
September 30, 2021 | -2.00M |
June 30, 2021 | -24.00M |
March 31, 2021 | 26.00M |
Date | Value |
---|---|
December 31, 2020 | 44.00M |
September 30, 2020 | 30.00M |
June 30, 2020 | 1.381B |
March 31, 2020 | 578.00M |
December 31, 2019 | 31.72M |
September 30, 2019 | 15.81M |
June 30, 2019 | 4.177M |
March 31, 2019 | 0.293M |
December 31, 2018 | 575.92M |
September 30, 2018 | -9.43M |
June 30, 2018 | 110.36M |
March 31, 2018 | 550.00M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-1.327B
Minimum
Jun 2022
1.381B
Maximum
Jun 2020
-190.17M
Average
-24.00M
Median
Jun 2021
Cash from Financing (Quarterly) Benchmarks
Eli Lilly and Co | -311.30M |
Merck & Co Inc | -2.245B |
Pfizer Inc | 5.442B |
Johnson & Johnson | 546.00M |
Novavax Inc | 100.39M |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | 622.00M |
Cash from Investing (Quarterly) | -538.00M |
Free Cash Flow | -3.825B |
Free Cash Flow Per Share (Quarterly) | 1.052 |
Free Cash Flow to Equity (Quarterly) | 402.00M |
Free Cash Flow to Firm (Quarterly) | 402.00M |
Free Cash Flow Yield | -8.10% |